Anaptysbio ANAB
NASDAQ ANAB
$48.78 +0.15 (+0.31%)
As of: Oct 2, 2026 · 11:19 AM EDT

Anaptysbio (ANAB) Net Equity Issued and Repurchased (2016 - 2026)

Updated

Anaptysbio (ANAB) posted Net Equity Issued and Repurchased of $14.02 million for Q1 2026, compared with $290,000 a year earlier and up 14.8% from the prior quarter.

Analysis

Anaptysbio (ANAB) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Net Equity Issued and Repurchased at Anaptysbio was $27.99 million, up 962.3% year-over-year; for FY2025, it came in at $14.26 million, up 120.3% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 95.8% (FY2020 to FY2025).
  • In prior years, Anaptysbio's Net Equity Issued and Repurchased was $6.47 million in FY2024 (+161.9%), $2.47 million in FY2023 (-79.1%), $11.83 million in FY2022 (+363.3%) and $2.55 million in FY2021 (+414.7%).
  • The Q1 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q3 2018.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last four quarters, with growth averaging 29.1%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2021, with growth of 680.3%; the weakest was Q3 2023, with a decline of 94.1%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $12.21 million (Q4 2025), $336,000 (Q3 2025) and $1.42 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Anaptysbio 1.46 Bn 346.34 Mn - 14.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 14.02 Mn
Dec 31, 2025 12.21 Mn
Sep 30, 2025 336,000.00
Jun 30, 2025 1.42 Mn
Mar 31, 2025 290,000.00
Dec 31, 2024 555,000.00
Sep 30, 2024 4.13 Mn
Jun 30, 2024 979,000.00
Mar 31, 2024 811,000.00
Dec 31, 2023 264,000.00
Sep 30, 2023 160,000.00
Jun 30, 2023 783,000.00
Mar 31, 2023 1.27 Mn
Dec 31, 2022 3.42 Mn
Sep 30, 2022 2.70 Mn
Jun 30, 2022 865,000.00
Mar 31, 2022 4.84 Mn
Dec 31, 2021 1.59 Mn
Sep 30, 2021 241,000.00
Jun 30, 2021 554,000.00
API Access

Anaptysbio Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANAB&period=max&api_key=YOUR_API_KEY